ethosuximide has been researched along with Refractory Depression in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J | 1 |
| Wang, Z | 1 |
| Dong, Y | 1 |
| Yang, Y | 1 |
| Ng, CH | 1 |
| Ma, S | 1 |
| Xu, Y | 1 |
| Hu, H | 1 |
| Hu, S | 1 |
1 trial available for ethosuximide and Refractory Depression
| Article | Year |
|---|---|
A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression.
Topics: Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Ethosuximide; | 2019 |